Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 16.26
-0.69 (-4.07%)
Jun 2, 2026, 3:00 PM CST
SHA:688670 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -183.27 | -178.46 | -93.58 | -70.99 | 41.54 | 82.46 |
Depreciation & Amortization | 28.86 | 28.86 | 30 | 29.87 | 29.76 | 28.08 |
Other Amortization | 2.26 | 2.26 | 0.42 | 1.38 | 1.38 | 1.13 |
Loss (Gain) From Sale of Assets | -0 | -0 | 0.1 | - | -0.23 | 0.05 |
Asset Writedown & Restructuring Costs | 11.66 | 11.66 | 4.68 | 1.11 | 38.35 | 57.94 |
Loss (Gain) From Sale of Investments | -6.02 | -6.02 | -12.1 | -13.1 | -14.13 | -7.26 |
Provision & Write-off of Bad Debts | 4.23 | 4.23 | 2.68 | -11.25 | 1.15 | - |
Other Operating Activities | 38.13 | 18.44 | 21.5 | 56.69 | 1.28 | 9.85 |
Change in Accounts Receivable | -29.72 | -29.72 | -13.82 | 241.61 | -7.19 | 13.37 |
Change in Inventory | 1.43 | 1.43 | -32.85 | -44.83 | -39.03 | -48.91 |
Change in Accounts Payable | -0.37 | -0.37 | -15.95 | -93.99 | -18.82 | -20.13 |
Change in Other Net Operating Assets | - | - | - | - | 0.76 | 0.73 |
Operating Cash Flow | -151.57 | -166.45 | -131.39 | 80.9 | 38.6 | 103.93 |
Operating Cash Flow Growth | - | - | - | 109.62% | -62.86% | -5.05% |
Capital Expenditures | -52.4 | -34.97 | -38.48 | -54 | -168.18 | -386.39 |
Sale of Property, Plant & Equipment | 0 | 0 | 0.27 | - | - | 0.05 |
Investment in Securities | 147.8 | 147.8 | 188.98 | -145 | 280.87 | -615 |
Other Investing Activities | -22.3 | 21.05 | -3.25 | 11.3 | - | 4.95 |
Investing Cash Flow | 73.1 | 133.88 | 147.51 | -187.71 | 112.7 | -996.39 |
Short-Term Debt Issued | - | 103 | 74.6 | 66 | 52 | 229.61 |
Total Debt Issued | 109 | 103 | 74.6 | 66 | 52 | 229.61 |
Short-Term Debt Repaid | - | -52.6 | -91 | -44 | -20 | -515.96 |
Total Debt Repaid | -57.6 | -52.6 | -91 | -44 | -20 | -515.96 |
Net Debt Issued (Repaid) | 51.4 | 50.4 | -16.4 | 22 | 32 | -286.35 |
Issuance of Common Stock | - | - | - | - | - | 1,150 |
Common Dividends Paid | -1.54 | -1.26 | -1.63 | -17.6 | -45.25 | - |
Other Financing Activities | - | - | - | -1.88 | - | -22.98 |
Financing Cash Flow | 49.86 | 49.14 | -18.03 | 2.52 | -13.25 | 841.14 |
Foreign Exchange Rate Adjustments | - | - | - | - | 0 | - |
Net Cash Flow | -28.62 | 16.57 | -1.9 | -104.29 | 138.04 | -51.33 |
Free Cash Flow | -203.97 | -201.42 | -169.87 | 26.9 | -129.58 | -282.46 |
Free Cash Flow Margin | -184.90% | -178.43% | -210.22% | 19.99% | -40.69% | -72.01% |
Free Cash Flow Per Share | -1.66 | -1.64 | -1.38 | 0.22 | -1.06 | -2.69 |
Cash Interest Paid | - | - | - | 1.88 | - | 9.85 |
Cash Income Tax Paid | 6.58 | 6.22 | 5.01 | 7.27 | 20.62 | 43.48 |
Levered Free Cash Flow | -19.4 | -128.16 | -123.83 | 93.07 | -80.61 | -297.59 |
Unlevered Free Cash Flow | -18.41 | -127.36 | -122.83 | 94.26 | -79.81 | -291.44 |
Change in Working Capital | -47.41 | -47.41 | -85.09 | 87.2 | -60.5 | -69.59 |